Chemoinformaics analysis of 1,1-Dimethyl-3-methylene-2-vinylcyclohexane
| Molecular Weight | 150.265 | nRot | 1 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 8 |
| Exact Molecular Weight | 150.141 | nRing | 1 |
| Solubility: LogS | -4.672 | nHRing | 0 |
| Solubility: LogP | 3.993 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 30.3723 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.501 |
| Synth | 3.695 |
| Natural Product Likeliness | 2.915 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.012 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.446 |
| MDCK | 0.0000212 |
| BBB | 0.96 |
| PPB | 0.886561 |
| VDSS | 1.623 |
| FU | 0.0217524 |
| CYP1A2-inh | 0.266 |
| CYP1A2-sub | 0.746 |
| CYP2c19-inh | 0.261 |
| CYP2c19-sub | 0.893 |
| CYP2c9-inh | 0.322 |
| CYP2c9-sub | 0.891 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.897 |
| CYP3a4-inh | 0.118 |
| CYP3a4-sub | 0.285 |
| CL | 4.468 |
| T12 | 0.106 |
| hERG | 0.009 |
| Ames | 0.032 |
| ROA | 0.134 |
| SkinSen | 0.039 |
| Carcinogencity | 0.09 |
| EI | 0.933 |
| Respiratory | 0.931 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.861875 |